Okyo Pharma LTD 6-K Filing
Ticker: OKYO · Form: 6-K · Filed: Dec 15, 2025 · CIK: 1849296
Sentiment: neutral
Filing Stats: 351 words · 1 min read · ~1 pages · Grade level 15.3 · Accepted 2025-12-15 08:30:07
Filing Documents
- form6-k.htm (6-K) — 22KB
- ex99-1.htm (EX-99.1) — 8KB
- ex99-1_001.jpg (GRAPHIC) — 4KB
- 0001493152-25-027658.txt ( ) — 37KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. OKYO Pharma LTD Date: December 15, 2025 By: /s/ Keeren Shah Name: Keeren Shah Title: Chief Financial Officer 3 EXHIBIT INDEX Exhibit No. Description 99.1 News Announcement, dated December 15, 2025 4